(Q44013179)

28 November 2017

title

EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole (English)

1 reference

28 November 2017

William W Hope

4

0 references

Cornelia Lass-Florl

3

object named as

Cornelia Lass-Flörl

1 reference

28 November 2017

Manuel Cuenca-Estrella

2

object named as

Manuel Cuenca-Estrella

1 reference

28 November 2017

author name string

Maiken Cavling Arendrup

1

1 reference

28 November 2017

European Committee on Antimicrobial Susceptibility Testing - Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST)

5

1 reference

28 November 2017

publication date

13 January 2014

1 reference

28 November 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

Mycoses

1 reference

28 November 2017

volume

57

1 reference

28 November 2017

issue

6

1 reference

28 November 2017

page(s)

377-379

1 reference

A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.

28 November 2017

cites work

1 reference

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

21 January 2018

1 reference

Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial

21 January 2018

1 reference

Breakthrough invasive candidiasis in patients on micafungin

21 January 2018

1 reference

Disseminated Candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafungin

21 January 2018

1 reference

Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts

21 January 2018

1 reference

Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations

21 January 2018

1 reference

Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia

21 January 2018

1 reference

EUCAST technical note on anidulafungin

21 January 2018

1 reference

Anidulafungin versus fluconazole for invasive candidiasis

21 January 2018

1 reference

In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species

21 January 2018

1 reference

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

21 January 2018

1 reference

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).

21 January 2018

1 reference

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

EUCAST technical note on fluconazole

21 January 2018

1 reference

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

21 January 2018

1 reference

Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates

21 January 2018

1 reference

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/MYC.12170

1 reference

28 November 2017

1 reference